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Upper EgyptAbstract Background: We aimed to report our experience with the use of multidetector row com-
puted tomography (MDCT), with angiography in the evaluation of patients with hemoptysis.
Methods: A prospective study was carried out on 52 patients suffering from hemoptysis, from
May 2011 to August 2014. They underwent MDCT using a 16-detector row scanner with bronchial
and pulmonary angiographic techniques.
Results: MDCT identified the cause of hemoptysis in 92% of patients. MDCT angiography was
able to detect the site and vascular source of bleeding in 85% of patients. A total of 92 bronchial
arteries were detected in 65% of patients; 29 of these arteries (31%) were abnormally dilated.
Conclusion: Our results confirm that MDCT angiography is a useful method to identify and
depict the bronchial arteries and to predict the presence of nonbronchial systemic vessels that
supply a parenchymal lesion. MDCT angiography allows a rapid and detailed identification of
abnormal vasculature and provides a precise road map which can be used to guide therapeutic
arterial embolization.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).y; DSA,
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Hemoptysis is defined as bleeding arising from the lower air-
ways [1]. Identifying the etiology of hemoptysis and classifying
it in terms of the amount of blood expectorated as well as the
rate of bleeding play a fundamental role in defining the timing,
way and place of managing a patient with hemoptysis [2].
There are multiple causes of hemoptysis, including airway
diseases, parenchymal lung diseases, cardiovascular diseases,
and others [3]. However, no cause is identified in 15–30% of
all cases, and is termed idiopathic or cryptogenic hemoptysis
[4]. In the majority of cases, the source of massive hemoptysis
is the bronchial circulation. However, nonbronchial systemic
arteries can be also a significant source [5].
Imaging modalities pertinent to the evaluation of hemopty-
sis include chest radiography, computed tomography (CT),
and bronchial arteriography.
Conditions such as bronchiectasis, chronic bronchitis, lung
malignancy, tuberculosis, and chronic fungal infection are
easily detected with conventional CT [6]. Even, CT is superior
to fiberoptic bronchoscopy in finding a cause of hemoptysis, its
main advantage being its ability to show distal airways beyond
the reach of the bronchoscope, and the lung parenchyma sur-
rounding these distal airways [4].
However, more recently, the development of multidetector
row CT (MDCT) has provided a comprehensive, noninvasive
method of evaluating the entire thorax [1,7]. At the same time,
the combined use of thin-section axial scans and more complex
reformatted images allows clear depiction of the origins and
trajectories of abnormally dilated bronchial or non-bronchial
systemic arteries that may be the source of hemorrhage requir-
ing embolization [5,7].
Assiut University Hospital is a tertiary referral center,
where many patients, from all over Upper Egypt, are referred
for the evaluation and management of hemoptysis. Therefore,
in the current study, we aimed to report our experience with
the use of MDCT, especially with its new applications such
as reformatted images, high resolution imaging and post-
processing techniques, in the management of patients with
hemoptysis. We aimed also to determine the additional benefit
of MDCT angiographic technique in identifying the site of
bleeding and its vascular origin.
Patients and methods
Patients
This prospective study was carried out on 52 patients suffering
from hemoptysis, enrolled from May 2011 to August 2014.
These patients included those admitted to the Department of
Chest Diseases, Assiut University Hospital, and those patients
with known lung cancer who presented with hemoptysis during
their admission or outpatient follow up at the Department of
Medical Oncology, South Egypt Cancer Institute (SECI). All
patients were subjected to complete clinical assessment. A
detailed history was obtained.
The volume of hemoptysis corresponds to the cumulated
amount of bleeding, which was assessed from the onset of
bleeding until time of CT examination using a standardized
scale: spoonful (5 mL), small filled glass (100 mL), and
large filled glass (200 mL). According to the severity ofhemoptysis, it was classified as ‘‘mild” (<30 mL), ‘‘moderate”
(30–600 mL), ‘‘severe” or ‘‘massive” (>600 mL) [8].
Exclusion criteria included (1) pregnant females. (2)
Patients with chronic renal failure (or impairment) not on reg-
ular dialysis. (3) Patients who are hemodynamically unstable.
(4) Severe cardiac disease causing orthopnea. (5) Sensitivity
to the contrast medium. (6) Patients with life-threatening
hemoptysis till been stabilized.
Full clinical examination was carried out. Laboratory data
were reviewed particularly for platelet count and coagulation
profile.
All enrolled patients were subjected to plain chest X-ray
and MDCT for assessment of the integrity of pulmonary
and/or systemic circulation.
Fiberoptic bronchoscopy (FOB) with histopathologic
examination was carried out in some selected patients (sus-
pected lung cancer, unresolved pneumonia). Digital subtrac-
tion angiography (DSA) was carried out in those patients
planned to undergo embolization procedure.
The study was approved by the local ethics committee of
both the health care facilities and a written consent was
obtained from all patients who participated in the study.
Multidetector CT
Patient preparation
All patients were instructed to fast 6 h prior to the examina-
tion. All steps of the study were explained in detail for each
patient. An IV access was secured (an 18 G cannula).
Scan protocol
A 16-detector row scanner General Electric (Light Speed Ultra
16; GE Medical Systems) was used. Pre & post contrast CT
studies were performed in all patients. CT imaging was per-
formed with patients in the supine position at maximal inspira-
tion during a single breath hold.
Acquisition
First, a scout view of the thorax is used to plan CT data acqui-
sition. A 28–33 cm field of view, 512  512 matrix size, and a
collimation of 1.25 mm and 1.5–2 pitch were used. The mean
acquisition time was 12–18 s. By adjusting the exposure
parameters, kilovoltage (100–140) and milliampere-seconds
(90–140) according to the patients’ weight the radiation dose
to the patient can be minimized without composing image
quality.
The MDCT bronchial angiographic technique
CT imaging had been acquired from the supraclavicular area
to the level of the ostia of the renal arteries, including the
supraaortic great vessels and the infra-diaphragmatic arteries,
which may also supply collateral branches to the lungs. Opti-
mal enhancement of both the pulmonary and systemic arteries
was achieved with the injection of 120 mL of a high-density,
low osmolar non-ionic contrast medium (350 mg/dL) with an
automated injector at a rate of 4 mL/s via an antecubital vein.
The automatic bolus triggering software program was also sys-
tematically applied, with a circular region of interest posi-
tioned at the descending aorta at the level of carina, and as
the threshold value of 100 HU was approached, craniocaudal
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tion of selected reformatted images is done. Assessment of
the lung parenchyma and airways as well as the mediastinum
was always done as in routine CT chest studies, using both
lung parenchyma and mediastinal window settings.
Post processing techniques
Post-processing of the raw data was performed with axial thin
section images, multiplanner reformation (MPR), interactive
maximum intensity projection (MIP), and volume-rendered
(VR) techniques in order to optimally evaluate the origins
and courses of the bronchial and non-bronchial systemic arter-
ies (NBSAs).
Data interpretation for routine CT chest
CT was analyzed to look for the cause of hemoptysis and to
localize the site of hemoptysis. Images were viewed in the lung
and mediastinal window to look for parenchymal changes, any
lymphadenopathy, pleural thickening, and major vessels.
Analysis of bronchial arteries
CT interpretation was done by using axial images, multiplanar
reformation images, and 3-dimensional reconstructions
(MIP and VR) images to identify bronchial arteries, and the
following parameters were recorded:(1) the total number of
bronchial arteries per side; (2) the site of the ostium of the
bronchial artery (or arteries); (3) location of the ostium on
the wall of the descending aorta (ie, posterior, medial, anterior,
or lateral), and its position relative to the tracheal carina, (4)
bronchial artery diameter; (5) visualized course of bronchial
arteries.
Bronchial arteries were considered abnormal when (a) the
diameter of the bronchial artery wasP2 mm, or (b) the course
of the bronchial artery was visualized up to the hilum. The
bronchial artery that satisfied either or both of these criteria
was considered an abnormal hypertrophied artery and as a
source of hemoptysis.
The origin of bronchial artery was considered orthotopic
when the origin was from the descending aorta between
the levels of the T5 and T6 vertebrae and ectopic when identi-
fied at a level of the descending aorta other than the expected
origin (ie, outside levels T5–T6) or from any aortic branch
vessel.
Analyses of non-bronchial systemic arteries
Arteries that enter the lung parenchyma through the inferior
pulmonary ligament or through the adherent pleura and with
trajectories that are not parallel to the bronchi are considered
as non-bronchial arteries. They were considered abnormal
when they become dilated and tortuous, and were seen within
extrapleural fat in association with pleural thickening
(P3 mm) and/or lung parenchyma abnormalities. Whenever
an abnormal nonbronchial systemic artery was identified, its
origin and course were noted.
Digital subtraction angiography (DSA)
DSA was carried out in those patients for whom embolization
procedure was anticipated. DSA was performed within a med-
ian period of 5 days (range, 1–20 days) after CT, dependingupon the clinical condition of the patient; where 70–120 mL
of nonionic (iohexol [Omnipaque; GE Healthcare, Princeton,
NJ]) contrast agent was used. Angiographic procedures were
performed with the knowledge of CT findings. For selective
bronchial engagement, 5F/4F curved catheters such as the
Simmons, celiac, picard, and renal double curve were used,
and microcatheters were used when required. Arteriography
also was done for nonbronchial systemic arteries when
required.
The following angiographic findings were considered to be
predictive of the vessels responsible for hemoptysis: (a) tortu-
ous enlargement of bronchial and/or nonbronchial systemic
arteries that supplied the area of parenchymal staining, and
(b) a shunt into pulmonary vessels. The results of angiography
were compared with the results of MDCT.
Statistical analysis
Data were analyzed using the Statistical Product and Service
Solutions (Windows version 16.0; SPSS Inc. Chicago, USA).
Results
Fifty-two patients were prospectively enrolled into the current
study. They included 41 (79%) patients admitted to the
Department of Chest Diseases, Assiut University Hospital,
and 11 (21%) patients with known LC admitted to the SECI.
The patients included 37 (71%) males and 15 (29%) females
with a mean age of 50 years (range from 20 to 75). Twelve
(23%) and 34 (65%) patients had mild and moderate hemop-
tysis, respectively while 6 (12%) patients were reported to have
severe hemoptysis.
The cause of hemoptysis was primarily diagnosed from the
patient’s history, physical examination and chest radiography.
Final diagnosis was established by applying all clinical, labora-
tory, radiographic, MDCT, bronchoscopic, conventional
angiographic findings and histopathology (if done). The most
encountered cause of hemoptysis in our cohort was lung can-
cer, in 24 (46%) patients; followed by TB sequelae and
bronchiectasis, in 11 (21%) and 6 (11.5%) patients, respec-
tively. Table 1 shows the patient demographics and the grades
and etiology of hemoptysis.
Chest X ray was done in all patients. Many radiographic
findings have been identified, including mass in 11(21%), local-
ized patch of consolidation in 2 (4%), bronchiectasis in 3
(5.5%), and cavitary lesion in 4 (7.5%) patients, respectively.
Overall, plain radiography was considered successfully con-
tributing in identification of the cause of hemoptysis in only
20/52 patients (38%). Fiberoptic bronchoscopy was carried
out in 10 (19%) patients. It revealed the cause of bleeding in
8 (80%) patients, 6 patients had central bronchogenic carci-
noma (proved by histopathological confirmation), and 2
patients had focal endobronchial mass.
MDCT identified the cause of hemoptysis in total 48 out of
52 patients (92%). Those 48 patients included 37 (71%)
patients with lung parenchymal abnormalities and 11 (21%)
patients with isolated vascular abnormalities without
parenchymal abnormalities. Among those 37 patients with
lung parenchymal abnormalities; 33 (63%) patients had asso-
ciated vascular abnormalities (Figs. 1 and 2) and 4(8%)
patients had no associated vascular abnormality. In the
Table 1 Demographic data, grades and etiology of hemop-
tysis in the studied patients.*
Parameter Patients No (percent)
Age (years)
Mean ± SD 50.15 ± 14.61
Range 20.0–75.0
Gender
Male 37 (71%)
Female 15 (29%)
Grade of hemoptysis
Mild 12 (23%)
Moderate 34 (65%)
Severe 6 (12%)
Etiology of hemoptysis
Lung cancer 24 (46.1%)
Suspected 10
Known 14
TB sequelae 11 (21.1%)
Bronchiectasis 6 (11.5%)
Pneumonia 5 (9.6%)
Pulmonary embolism 4 (7.7%)
Pulmonary AVM 1 (2%)
Cryptogenic 1 (2%)
* TB, tuberculosis; AVM, arteriovenous malformation.
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parenchymal nor vascular abnormalities were detected as the
cause of hemoptysis. Table 2 shows details of these results.
MDCT angiography was able to detect the vascular source
of bleeding in 44 out of 52 (85%) of the studied cohort. Bron-
chial arteries were the major source of bleeding, being detected
in 31 (60%) patients. Table 3 shows these vascular abnormal-
ities and their relation to parenchymal abnormalities.
A total of 92 bronchial arteries were detected in 34 out of 52
(65%) patients (30 right BAs; 2 patients had 2 double right-
sided BA, and 62 left BAs; 56 patients had double left-sided
BA) (Figs. 1 and 2) Twenty-nine out of 92 detected BAs
(31%) were seen to be dilated (>2 mm) in 29 patients (16 right
BAs and 13 left BAs) (Table 4). Forty-nine out of 92 (53%)
detected bronchial arteries were traceable to the level of pul-
monary hila.
With regards to the ostia of bronchial arteries, our results
showed that 82/92 (89%) of the BAs seen were orthotopic,
while 10/92 (11%) were ectopic (Table 4). The later were seen
in 8 patients, 5 were right-sided (3 from the aortic arch, and 2
from the subclavian artery) and 5 were left-sided (2 from the
aortic arch and 3 from lower part of descending thoracic
aorta).
Notably, the origins of orthotopic mediastinal Bas were
best depicted on overlapping axial thin-section images Two-
dimensional MIP reformatted images in the coronal oblique
and sagittal planes readily depict the tortuous course of the
BAs from their origins (descending thoracic aorta) to the lungs
along the main bronchi; whereas reformatted images in
straight coronal planes were better suited for analysis of the
intercostals and internal mammary arteries; and axial recon-
structed images were ideal for demonstrating the inferior phre-
nic arteries and branches from the celiac axis (Figs. 1, 3 and 5).
Non-bronchial systemic source of bleeding was encoun-
tered in 6 (11.5%) patients (Table 3) in the form of: dilatedintercostals vessels with pleural thickening (>3 mm) and in
association with parenchymal lung abnormalities in all of these
patients.
The pulmonary circulation contributed to hemoptysis in 7
(13.5%) patients (Table 3 and Fig. 3), 4 of them had pul-
monary embolism (Table 2 and Fig. 4) and 1 patient had arte-
riovenous malformation; AVM (Fig. 5).
DSA was performed after MDCT study in 9 (17%) patients
who were indicated for embolization and showed positive find-
ings in 8/9 (88.9%) patients, where abnormal BAs were identi-
fied in 7 patients and an abnormal NBSA was seen in one
patient. (Figs. 1 and 2).
Upon comparing the findings with MDCT, all the BAs
were prospectively identified as abnormal by MDCT.
Discussion
The current prospective study aimed to evaluate the role of
MDCT in the management of hemoptysis of different etiolo-
gies and degrees among 52 patients, enrolled through a
3-year period, in Upper Egypt. To the best of our knowledge,
this is the first study reporting the utility of MDCT, with
bronchial and pulmonary angiography in the management of
hemoptysis in Upper Egypt.
Identifying the etiology of hemoptysis and classifying it in
terms of the amount of blood expectorated, as well as the rate
of bleeding play a fundamental role in optimizing the manage-
ment strategy and deciding whether or not an embolization
procedure is needed. Our data showed that lung cancer was
the most encountered cause for hemoptysis in our patients
(46%), followed by those underlying chronic lung diseases with
extensive vascular abnormalities, like TB sequelae and
bronchiectasis, in 21% and 11.5% patients, respectively.
Despite the fact that the current study was carried out at
the same locality (Upper Egypt) of the study by Agmy et al.
[2], common etiologies of hemoptysis are clearly different
between the 2 studies, which may be explained by the differ-
ence in patients’ numbers. Moreover, lung cancer, being the
most common etiology in the current study can be explained
by enrollment of 11/52 (21%) patients with known lung cancer
into the study. Our results are still in agreement with those of
Hirshberg et al. [9] who found that lung cancer and bronchiec-
tasis were the causes of hemoptysis in 20% and 19% of their
patients, respectively.
Despite the fact that bronchial arteries are the most com-
mon source of massive or life-threatening hemoptysis due to
the high pressure of that circuit, non-bronchial systemic circu-
lation may contribute between 10% and 30% of cases [10]
Missing the nonbronchial systemic arteries at initial angiogra-
phy may result in early recurrent bleeding after successful
embolization of the bronchial artery. So, a comprehensive
search for non-bronchial systemic arterial supply should be
made [2].
The normal BA is a small vessel that arises directly from the
descending thoracic aorta and supplies blood to the airway of
the lung, esophagus, and lymph nodes [11] Bronchial arteries
show substantial anatomic variations in their origins, branch-
ing patterns, and courses [12]. The right intercostobronchial
trunk, which usually arises from the right posterolateral aspect
of the thoracic aorta at the level of the 5th thoracic vertebra or
6th thoracic vertebra, is the most constant vessel. In approxi-
Figure 1 Male patient, 65 years old, presented with moderate haemoptysis for 2 weeks. MDCT of the chest; (A) Axial post contrast
image (mediastinal window) shows bilateral consolidation with an air bronchogram with bilateral minimal pleural reaction. Note a dilated
orthotopic left bronchial artery (white arrow). (B) Coronal image shows bilateral consolidation with a dilated left bronchial artery (white
arrow), the diameter of which was 4.1 mm (axial view, C). A 3-D volumetric reformatted image (D) and conventional angiography also
show this dilated artery.
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BAs that arise from the aorta as a common trunk are not unu-
sual. BAs are identified in the posterior mediastinum as dots or
lines of increased attenuation [13]. More than 30% of BAs
have an anomalous origin, which is a cause of endovascular
treatment failure [5]. Anomalous BAs may originate from
the aortic arch, internal mammary artery, thyrocervical trunk,
subclavian artery, costocervical trunk, brachiocephalic artery,
peri-cardiophrenic artery, inferior phrenic artery, or abdomi-
nal aorta [5].
Imaging modalities used in the evaluation of hemoptysis
include chest radiography, computed tomography, and bron-chial arteriography. However, more recently, the development
of multidetector row CT (MDCT) has provided a comprehen-
sive, noninvasive method for evaluating the entire thorax [1,7].
At the same time, the combined use of thin-section axial scans
and more complex reformatted images allows clear depiction
of the origins and trajectories of abnormally dilated bronchial
or non-bronchial systemic arteries that may be the source of
hemorrhage requiring embolization [5,7].
In the current study, chest radiography contributed to the
diagnosis of hemoptysis in 20/52 (38%) patients. This finding
is nearly consistent with those obtained by Abdel-Ghany
et al. [14] and Revel et al. [15], who reported that chest radio-
Figure 2 Male patient 55 years old, complaining of recurrent hemoptysis. MDCT of the chest; (A) Axial image (pulmonary window)
showing bronchiectatic changes of the left lung with abnormal hyperdense patchy shadows inside the dilated bronchi (B). Axial MDCT
(mediastinal window) at the carinal level shows dilated left bronchial artery (big arrow) with multiple nodular densities (small arrows).
Conventional angiography (D) shows an enlarged tortuous left bronchial vessel at the same level.
Table 2 MDCT findings in the studied patients.*
Parenchymal abnormality Patients No
(percent)
Specific parenchymal abnormality 33 (63%)
Mass 2
TB sequelae 10
Bronchiectasis 6
Endobronchial mass with/without
obstruction
15
Non-specific parenchymal abnormality
(Consolidation/ground-glass opacity)
4 (8%)
Pneumonia 4
No parenchymal abnormality 11 (21%)
Bronchial artery vascular abnormality
(dilatation/dysplasia)
6
Pulmonary artery vascular abnormality 5
Pulmonary embolism 4
Pulmonary AVM 1
Unidentified abnormality 4 (8%)
* TB, tuberculosis; AVM, arteriovenous malformation.
336 S.A.A. Mohamed et al.graphy contributed to diagnosis of hemoptysis in 44% and
46% of patients, respectively.
Our data revealed that, MDCT identified the cause of
hemoptysis in 48 out of 52 patients (92%). These results are
in agreement to those reported by Khalil et al., 90.5% [16]
and even better than those reported by 2 Egyptian studies(86%, by Ismaeel et al. [8] and 84%, by Abdel-Ghany et al.
[14].
With regards to the bleeding site localization, our data
revealed that, the presence of bleeding was detected by abnor-
mal CT findings in the form of focal parenchymal abnormality
or opacity (either ground glass opacity or consolidation) that is
not gravity-dependent. Diffuse opacities or those predomi-
nantly in the dependent portion of the lungs were considered
non-localizing. Three types of non-specific radiologic MDCT
abnormalities were prescribed in the literature [5,15,16]: (1)
ground-glass opacities and/or (2) alveolar consolidation; the
latter abnormalities were considered to reflect the filling of the
alveolar lumen with blood, and (3) atelectasis, induced by clots
obstructing the bronchi. The presence of alveolar filling, cavita-
tion and/or a mass was considered to be localizing lesions.
Our data showed that MDCT angiography was able to
detect the vascular source of bleeding in 44/52 (85%) of
patients. Bronchial arteries were the major source of bleeding,
being detected in 31 (60%) patients. A total of 92 BAs were
detected in 34 out of 52 (65%) patients (30 right BAs and 62
left BAs). In the study by Abdel-Ghany et al. [14], MDCT
chest with angiography detected 93 bronchial arteries in
32/50 (64%) patients. Using a 16-MDCT, Yoon, et al. [17],
were able to detect 52 bronchial arteries in 22 patients.
Interestingly, 29 out of 92 detected BAs (31%) were seen to
be dilated (>2 mm) in 29 patients (16 right BAs and 13 left
BAs). Gupta and coworkers [5], with the use of a cutoff value
of 2 mm on MDCT, could prospectively detect all abnormal
bronchial arteries by MDCT before detecting them later with
conventional angiography.
Table 3 Source of bleeding detected by MDCT and its relation to parenchymal abnormality.
Source of bleeding No of patients (%) With parenchymal
abnormality No (%)
Without parenchymal
abnormality No (%)
Bronchial artery Supply 31 (60%) 25 6
Non-bronchial systemic artery 6 (11.5%) 6 0
Pulmonary artery 7 (13.5%) 2 5
Not detected 8 (15%) 4 4
Table 4 Radiologic criteria of Bronchial arteries depicted on
MDCT angiography.
Detected bronchial arteries
Orthotopic
(82/92, 89%)
Ectopic
(10/92, 11%)
Right (30)
Dilated 16 2
Non-dilated 9 3
Left (62)
Dilated 13 0
Non-dilated 44 5
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chial arteries. We demonstrated that 82/92 (89%) of the BAs
seen in our study were orthotopic, while 10/92 (11%) were
ectopic. Those ectopic arteries were seen in 8 patients, 5 wereFigure 3 70 year old male patient presented with fever and mild he
window) shows a right middle lobe fibrocavitary lesion surrounded
window) showing consolidation with a branch from the Rt pulmonar
rendering 3-D processed image showing focal dilatation of the segmenright-sided (3 from the aortic arch, and 2 from the subclavian
artery) and 5 were left-sided (2 from the aortic arch and 3 from
lower part of descending thoracic aorta). These findings are in
accordance with those reported in the literature. Abdel-Ghany
and colleagues [14] found that that 90% of the BAs seen were
orthotopic, and 10% were ectopic BAs (seen in 7 patients).
Another study showed that the ostia of the BAs were ortho-
topic in 92.6% and ectopic in 7.4% of patients, respectively [5].
In our series, 49 out of 92 (53%) detected bronchial arteries
were traceable to the level of pulmonary hila. Previous data
[14] demonstrated that 46% of detected bronchial vessels
(46%) were traceable to the pulmonary hilum, while Yoon
et al. [17], found that 65% of BAs were traceable from their
origins to the hilum. Helmy et al. [18] concluded that tortuosity
and traceability of the vessels directed toward the lesion are
important factors in identification of the source and site of
bleeding.
One of the major causes of recurrent hemoptysis after suc-
cessful embolization of bronchial arteries is the presence ofmoptysis for 2 weeks. MDCT chest; (A) Axial image (pulmonary
by a patchy area of consolidation. (B) Axial image (mediastinal
y artery is seen within the wall of the cavitary lesion. (C) Volume
tal pulmonary branch.
Figure 4 74 year old male patient presented with breathlessness, chest pains and hemoptysis of blood-tinged sputum for few days.
MDCT chest with angiography; axial (A) and coronal images (B and C) show multiple arterial filling defects noted in the right and left
descending pulmonary arteries as well as multiple arterial filling defects in the subsegmental branches, consistent with pulmonary
embolism.
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bronchial systemic arteries in 6 (11.5%) of our patients. They
were in the form of dilated intercostals vessels with pleural
thickening and in association with parenchymal lung abnor-
malities in all of these 6 patients. Gupta and colleagues [5]
had identified nonbronchial systemic arteries in 11 of 27
patients (40.7%). Three of these patients (11.1%) had normal
bronchial arteries, and a nonbronchial systemic artery was the
only source of hemoptysis. In a study by Goh et al. [10] of 103
patients who underwent BAE, 42 had nonbronchial systemic
contributions (41%) and 12 had abnormal nonbronchial sys-
temic arteries but normal bronchial arteries (11.7%). Wong
et al. [19] found that nonbronchial collateral vessels supplied
the bleeding area in 14 of 16 patients with life-threatening
hemoptysis (88%). In 3 of those 16 patients (19%), bleeding
from systemic vessels other than the bronchial arteries was
the only source of hemoptysis.
Thus, our study also agrees with these studies and confirms
the significant contribution of nonbronchial systemic arteries
in patients with hemoptysis. Embolization of the nonbronchial
systemic arterial supply can lower the immediate recurrence
rate after successful embolization. Therefore, it is important
to identify these abnormal nonbronchial systemic arteries
before embolization.Along with the evaluation of systemic arteries, MDCT also
evaluates the pulmonary vasculature. Although in 95% of
cases of hemoptysis, the systemic arterial system is the origin
of the bleeding [12], pulmonary circulation can be the source
of hemoptysis in approximately 5% of cases. Detecting pul-
monary circulation as a source of hemoptysis before an inter-
ventional procedure changes the approach altogether. Various
causes of hemoptysis due to pulmonary circulation include
pulmonary emboli, Rasmussen aneurysm, direct invasion by
neoplastic disease, and pulmonary arteriovenous malforma-
tion (AVM) [5].
Notably, the pulmonary circulation contributed to hemop-
tysis in 7 (13.5%) of our cohort, characteristically 4 of them
had pulmonary embolism and 1 patient had AVM. In one
patient, a branch from the Rt pulmonary artery was seen
within the wall of a cavitary lesion in the right middle lobe
(Fig 3). Previous studies had reported that the pulmonary cir-
culation contributed to hemoptysis in 6.9% [20] and 10% [14]
of patients, respectively.
Conventional bronchial angiography was performed after
MDCT study in 9 (17%) patients who were indicated for
embolization and showed positive findings in 8/9 (88.9%)
patients, where abnormal BAs were identified in 7 patients
and an abnormal NBSA was seen in one patient. Upon com-
Figure 5 A female patient, 53 years old presented with mild hemoptysis of 3 weeks duration. MDCT chest with angiography; (A and B)
post contrast axial views (mediastinal window) show a well defined lobulated lesion at the left lower lung lobe. Note the serpigenous
vessels forming the lesion, which are also seen in the coronal (C) and sagittal (D) views. A 3-D volume rendering (E) shows a pulmonary
arteriovenous malformation (AVM) with a connection between the left inferior pulmonary vein and lower branch of left pulmonary
artery.
Utility of MDCT in Hemoptysis, Experience from Upper Egypt 339paring the findings with MDCT, all the BAs were prospec-
tively identified as abnormal by MDCT.
To summarize, our 3-year experience confirmed those
reported in the literature, that MDCT chest with angiography
is considered a primary noninvasive imaging modality in the
evaluation of patients with hemoptysis.
MDCT angiography is a useful method to identify and
depict the bronchial arteries and to predict the presence of
nonbronchial systemic vessels as well as pulmonary vascula-
ture that supply a parenchymal lesion.
The current study has some limitations. First, we have used
a 16-detector row MDCT device, Morita et al. [21] demon-
strated that 64 slice CT scanners showed the bronchial artery
anatomy better than 16 slice scanners. Second, is that the selec-
tive conventional angiography and bronchoscopy were per-
formed in a limited number of patients.To confirm our results, a larger or multi-center study is
needed in which inter-observer variability, especially in defin-
ing BAs causing hemoptysis and those not causing hemoptysis,
is recommended with use of MDCT and conventional angiog-
raphy in all enrolled subjects.
Conclusion
Our 3-year experience confirms that MDCT chest with angiog-
raphy is a useful method to identify and depict the bronchial
arteries and to predict the presence of nonbronchial systemic
vessels as well as pulmonary vasculature that supply a
parenchymal lesion. By using a variety of reformatted images,
MDCT angiography allows a rapid and detailed identification
of abnormal vasculature and provides a precise road map
340 S.A.A. Mohamed et al.which can be used to guide further therapeutic arterial
embolization procedures.
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